89bio, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ETNB on Nasdaq
Industry
Pharmaceutical Preparations
Location
142 Sansome Street, Second Floor, San Francisco, CA

Insiders trading volume in the past year

89bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $111M +$48.3M +77.8% Nov 14, 2024
Orbimed Advisors Llc 10%+ Owner $21.1M Jan 25, 2022
Rohan Palekar Chief Executive Officer, Director $3.72M -$1.06M -22.2% Dec 6, 2024
Quoc Le-Nguyen Chief Technical Operations Officer $2.23M -$227K -9.23% Dec 12, 2024
Harry H. Mansbach Chief Medical Officer $1.95M Dec 12, 2024
Michael R. Hayden Director $1.64M Feb 1, 2024
Ryan Martins Chief Financial Officer $1.56M Dec 12, 2024
Francis Sarena Chief Operating Officer $133K Aug 5, 2024
Ram Waisbourd Chief Operating Officer and Chief Business Officer $101K Feb 17, 2022
Charles McWherter Director $80K +$80K Dec 5, 2024
Derek DiRocco Director Feb 1, 2024
Lota S. Zoth Director Feb 1, 2024
Steven Altschuler Director Feb 1, 2024
Kathleen Laporte Director Feb 1, 2024
Gregory Grunberg Director, 10%+ Owner Feb 9, 2023
Edward Morrow Atkinson III Director Feb 1, 2024
Martin Babler Director May 2, 2024

Recent Insider Transactions by Companies or Individuals for 89bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.